Micro Market Research
+1-888-502-0539
US/CAN Toll Free

You are here :   Home     Healthcare     infertility Treatment     In Vitro Diagnostics    
Real Time Market Research & Industry Analysis - MicroMarketMonitor

European In Vitro Diagnostics Market

  • Report Code: IN 1002
  • Publish Date: Upcoming
  
Description
Table of Contents
Customer Intelligence
Summary
Inquiry Before Buying Ask for Discount

The European In Vitro Diagnostics Market is growing due to ongoing developments in analytical laboratory automation; the swift progress in various fields of diagnosis such as point-of-care testing, molecular diagnosis, immunoassays, hematology, flow cytometry, and microbiology; and finally, the geographical market expansion within emerging countries. The most important trend witnessed recently in the IVD industry is the trend of self-testing as opposed to patients visiting hospitals. This is one of the biggest factors responsible for the growth of point-of-care testing, as patients prefer self-testing so as to avoid unnecessary visits to the hospital.

 

In the last five years, the European IVD industry has witnessed challenging and dynamic market conditions in terms of rising incidences of chronic diseases, increasing awareness of health and fitness, as well as major technological advancements. The overall IVD market was worth $49.2 billion in 2013 and is estimated to grow at an annual growth rate of 7% over the next five years. The market displays a growing preference for mergers and acquisitions to ensure the sustainability and growth of a company.

 

In 2013, the Americas had the largest market, a 42% share of the European IVD market, followed by Europe with a 31% share. However, the BRIC countries represent the fastest-growing markets due to the economic growth, the rising number of chronic diseases, and an increasing awareness about the use of IVD tests to control the spread of diseases. Moreover, the economic slowdown, pricing pressures, and high competition in mature countries will compel companies to focus on emerging markets.

 

The major changes in In Vitro Diagnostics have been brought about as a result of the convergence of system engineering, automation, and IT technology. Thus, the new technologies have enabled a better understanding of disease processes. The In Vitro Diagnostics market is expanding, consolidating, and becoming highly competitive with myriad opportunities for various new instruments, reagents, calibrators, and other systems.

 

The Centers for Medicare & Medicaid Services (CMS) have estimated that healthcare spending in the U.S. is expected to grow from $2.7 trillion in 2011 to about $4.6 trillion in 2019, at a CAGR of 6.8% for the same period. Similarly, in emerging countries, awareness and an increasing middle-class population, with a more disposable income to spend on healthcare, will be a driving force for the growth of this market.

 

The report “European In Vitro Diagnostics Market forecast for 2018” analyzes the market by 5 segments such as reagents, instruments, techniques, applications and end-users. Germany commanded the largest share in European IVD market.

 

The report also provides an extensive competitive landscaping of companies operating in this market. The main companies operating in In Vitro Diagnostics Market and extensively covered in this report are Abbott Laboratories, Inc. (U.S.), Roche Diagnostics Limited (Switzerland), Becton, Dickson and Company (U.S.), Siemens Healthcare (Germany), Diagnostica Stago SAS (France), Danaher Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), ARKRAY, Inc. (Japan), Bio-Rad Laboratories, Inc. (U.S.), DiaSorin S.p.A. (Italy), Sysmex Corporation (Japan), bioMérieux (France), HORIBA, Ltd. (Japan), and Alere, Inc. (U.S.)

 

Segment and country specific company shares, news & deals, M&A, segment specific pipeline products, product approvals and product recalls of the major companies have been detailed.

 

Customization Options:

With the market data, you can also customize the MMM assessments that meet your company’s specific needs. Customize to get comprehensive industry standards and deep-dive analysis of the following parameters:

 

Opportunity Analysis

  • Unmet needs, revenue pockets and potential areas for expansion

 

Supplier Evaluation

  • Comprehensive review of key suppliers

 

Lab testing Data

  • Number of IVD tests performed annually in each country tracked till sub-segment level

 

Current and Emerging Products

  • Analysis of current and emerging In Vitro Diagnostics and immunodiagnostic tests
  • Review of current In Vitro Diagnostics instrumentation technologies, and feature comparison of high, medium, and low-volume/POC analyzers

 

Product Analysis

  • Usage pattern (in-depth trend analysis) of products (Segment wise)
  • Product Matrix which gives a detailed comparison of product portfolio of each company mapped at country and sub segment level
  • End-user Adoption rate analysis of the products (Segment wise and Country wise)
  • Comprehensive coverage of Product approvals, Pipeline products and Product recalls

 

Brand/Product Perception Matrix

  • Comprehensive study of customers perception and behavior through our inbuilt social connect tool checking the virility and tonality of blogs
  • Analysis of overall brand usage and familiarity and brand advocacy distribution (Detractor/Neutral/Familiar)

 

Alternative Products: Impact analysis

MMM’s Healthcare Decision Making Quadrant It is an innovative and useful quadrant for vendors who wish to analyze the potential growth markets based on parameters like Patient dynamics (Patient pool, epidemiology of disease, preference towards surgeries/alternative therapies) and Macroeconomic indicators (Number of Hospitals and Orthopedic clinics, reimbursement scenario, diagnosis rate, treatment rate and healthcare expenditure)



1 Introduction
1.1 Objective of the study
1.2 Market Definitions
1.3 Market Segmentation & Aspects Covered
1.4 Research Methodology
1.4.1 Assumptions (Market Size, Forecast, etc)
2 Executive Summary
3 Market Overview
4 In Vitro Diagnostics-Europe, By Segments
4.1 Split By Geography
4.1 In Vitro Diagnostics-Spain by Markets
4.1 In Vitro Diagnostics-United Kingdom by Markets
4.1 In Vitro Diagnostics-France by Markets
4.1 In Vitro Diagnostics-Germany by Markets
4.1 In Vitro Diagnostics-Italy by Markets
4.1 In Vitro Diagnostics-Rest of Europe by Markets
4.2 Clinical Chemistry-Europe
4.2.1 Clinical Chemistry-Europe, By Geographies
4.2.1.1 Clinical Chemistry-Spain
4.2.1.2 Clinical Chemistry-United Kingdom
4.2.1.3 Clinical Chemistry-France
4.2.1.4 Clinical Chemistry-Germany
4.2.1.5 Clinical Chemistry-Italy
4.2.1.6 Clinical Chemistry-Rest of Europe
4.2.2 Clinical Chemistry-Europe, By Products
4.2.2.1 Clinical Chemistry Services-Europe
4.2.2.2 Clinical Chemistry Instruments-Europe
4.2.2.3 Clinical Chemistry Reagents-Europe
4.3 Immunoassay-Europe
4.3.1 Immunoassay-Europe, By Applications
4.3.1.1 Immunoassay-Europe-Infectious disease
4.3.1.2 Immunoassay-Europe-Endocrine disorders
4.3.1.3 Immunoassay-Europe-Bone and Mineral Disorders
4.3.1.4 Immunoassay-Europe-Cancer
4.3.1.5 Immunoassay-Europe-Cardiovascular Disorders
4.3.1.6 Immunoassay-Europe-Blood Disorders
4.3.1.7 Immunoassay-Europe-Auto-immune Diseases
4.3.1.8 Immunoassay-Europe-Toxicology
4.3.2 Immunoassay-Europe, By Types
4.3.2.1 Immunoassay - Europe - Medium Throughput
4.3.2.2 Immunoassay - Europe - Medium Throughput
4.3.2.3 Immunoassay - Europe - Low Throughput
4.3.2.4 Immunoassay - Europe - Low Throughput
4.3.2.5 Immunoassay - Europe - High Throughput
4.3.2.6 Immunoassay - Europe - High Throughput
4.3.3 Immunoassay-Europe, By Geographies
4.3.3.1 Immunoassay-Spain
4.3.3.2 Immunoassay-United Kingdom
4.3.3.3 Immunoassay-France
4.3.3.4 Immunoassay-Germany
4.3.3.5 Immunoassay-Italy
4.3.3.6 Immunoassay-Rest of Europe
4.3.4 Immunoassay-Europe, By Technologies
4.3.4.1 Fluorescence Immunoassays (FIA)-Europe
4.3.4.2 Chemiluminescence Immunoassays (CLIA)-Europe
4.3.4.3 Radioimmunoassays (RIA)-Europe
4.3.4.4 Enzyme Immunoassays (EIA)-Europe
4.4 Hematology-Europe
4.4.1 Hematology-Europe, By Applications
4.4.1.1 Hematology-Europe-Infectious disease
4.4.1.2 Hematology-Europe-Auto-immune Diseases
4.4.1.3 Hematology-Europe-Genitourinary disorders
4.4.1.4 Hematology-Europe-Diabetes
4.4.1.5 Hematology-Europe-Cancer
4.4.1.6 Hematology-Europe-HIV/AIDS
4.4.1.7 Hematology-Europe-Cardiovascular Disorders
4.4.1.8 Hematology-Europe-Drug Testing
4.4.1.9 Hematology-Europe-
4.4.2 Hematology-Europe, By Endusers
4.4.2.1 Hematology-Europe-Hospitals
4.4.2.2 Hematology-Europe-Medical & Diagnostic Laboratories
4.4.2.3 Hematology-Europe-Patient Self Testing
4.4.2.4 Hematology-Europe-Point of Care Testing
4.4.2.5 Hematology-Europe-Academics
4.4.2.6 Hematology-Europe-
4.4.3 Hematology-Europe, By Geographies
4.4.3.1 Hematology-Spain
4.4.3.2 Hematology-United Kingdom
4.4.3.3 Hematology-France
4.4.3.4 Hematology-Germany
4.4.3.5 Hematology-Italy
4.4.3.6 Hematology-Rest of Europe
4.4.4 Hematology-Europe, By Products
4.4.4.1 Hematology Cell Counters-Europe
4.4.4.2 Hematology Analyzers-Europe
4.4.4.3 Immuno Hematology-Europe
4.4.4.4 Hematology Reagents-Europe
4.4.4.5 Hematology Services-Europe
4.4.4.6 Hematology Rapid Testing-Europe
4.4.4.7 Hemostasis-Europe
4.5 Coagulation-Europe
4.5.1 Coagulation-Europe, By Geographies
4.5.1.1 Coagulation-Spain
4.5.1.2 Coagulation-United Kingdom
4.5.1.3 Coagulation-France
4.5.1.4 Coagulation-Germany
4.5.1.5 Coagulation-Italy
4.5.1.6 Coagulation-Rest of Europe
4.6 Microbiology-Europe
4.6.1 Microbiology-Europe, By Geographies
4.6.1.1 Microbiology-Spain
4.6.1.2 Microbiology-United Kingdom
4.6.1.3 Microbiology-France
4.6.1.4 Microbiology-Germany
4.6.1.5 Microbiology-Italy
4.6.1.6 Microbiology-Rest of Europe
4.7 Others-Europe
4.7.1 Others-Europe, By Geographies
4.7.1.1 Others-Spain
4.7.1.2 Others-United Kingdom
4.7.1.3 Others-France
4.7.1.4 Others-Germany
4.7.1.5 Others-Italy
4.7.1.6 Others-Rest of Europe
4.8 Molecular Diagnostics-Europe
4.8.1 Molecular Diagnostics-Europe, By Endusers
4.8.1.1 Molecular Diagnostics-Europe-Hospitals
4.8.1.2 Molecular Diagnostics-Europe-Medical & Diagnostic Laboratories
4.8.1.3 Molecular Diagnostics--Europe
4.8.2 Molecular Diagnostics-Europe, By Technologies
4.8.2.1 Molecular Diagnostics-Transcription-mediated Amplification (TMA)-Europe
4.8.2.2 Molecular Diagnostics--Europe
4.8.3 Molecular Diagnostics-Europe, By Applications
4.8.3.1 Molecular Diagnostics-Genetic Testing-Europe
4.8.3.2 Molecular Diagnostics-Microbiology-Europe
4.8.3.3 Molecular Diagnostics-Chlamydia trachomatis/ Neisseria gonorrhoeae-Europe
4.8.3.4 Molecular Diagnostics-Hepatitis B-Europe
4.8.3.5 Molecular Diagnostics--Europe
4.8.3.6 Molecular Diagnostics-Breast Cancer-Europe
4.8.3.7 Molecular Diagnostics-Human Papillomavirus-Europe
4.8.3.8 Molecular Diagnostics-HIV/AIDS-Europe
4.8.3.9 Molecular Diagnostics-Tuberculosis-Europe
4.8.3.10 Molecular Diagnostics-Hepatitis C-Europe
4.8.3.11 Molecular Diagnostics-Methicillin-resistant Staphylococcus aureus (MRSA)-Europe
4.8.3.12 Molecular Diagnostics-Colorectal Cancer-Europe
4.8.3.13 Molecular Diagnostics-Prostate Cancer-Europe
4.8.4 Molecular Diagnostics-Europe, By Companies
4.8.4.1 Molecular Diagnostics-Novartis AG-Europe
4.8.4.2 Molecular Diagnostics-Novartis AG-Europe
4.8.4.3 Molecular Diagnostics-Novartis AG-Europe
4.8.4.4 Molecular Diagnostics-Abbott Diagnostics-Europe
4.8.4.5 Molecular Diagnostics-Other Companies-Europe
4.8.4.6 Molecular Diagnostics-Abbott Diagnostics-Europe
4.8.4.7 Molecular Diagnostics-Other Companies-Europe
4.8.4.8 Molecular Diagnostics-Abbott Diagnostics-Europe
4.8.4.9 Molecular Diagnostics-Other Companies-Europe
4.8.4.10 Molecular Diagnostics-Gen-Probe Incorporated-Europe
4.8.4.11 Molecular Diagnostics-Europe-Becton Dickinson & Company
4.8.4.12 Molecular Diagnostics-Europe-Cepheid
4.8.4.13 Molecular Diagnostics-Europe-BioMérieux
4.8.4.14 Molecular Diagnostics-Europe-Siemens AG Healthcare
4.8.5 Molecular Diagnostics-Europe, By Geographies
4.8.5.1 Molecular Diagnostics-Spain
4.8.5.2 Molecular Diagnostics-United Kingdom
4.8.5.3 Molecular Diagnostics-France
4.8.5.4 Molecular Diagnostics-Germany
4.8.5.5 Molecular Diagnostics-Italy
4.8.5.6 Molecular Diagnostics-Rest of Europe
4.8.6 Molecular Diagnostics-Europe, By Products
4.8.6.1 Molecular Diagnostics Instruments-Europe
4.8.6.2 Molecular Diagnostics Reagents-Europe
4.8.6.3 Molecular Diagnostics Services-Europe
4.9 Tissue Diagnostics-Europe
5 In Vitro Diagnostics-Europe, By Applications
5.1 Split By Geography
5.2 In Vitro Diagnostics-Spain by Applications
5.1 In Vitro Diagnostics-United Kingdom by Applications
5.1 In Vitro Diagnostics-France by Applications
5.1 In Vitro Diagnostics-Germany by Applications
5.1 In Vitro Diagnostics-Italy by Applications
5.1 In Vitro Diagnostics-Rest of Europe by Applications
5.2 In Vitro Diagnostics-Europe-Drug Testing
5.2.1 In Vitro Diagnostics-Europe-Drug Testing, By Geographies
5.2.1.1 In Vitro Diagnostics-Spain-Drug Testing
5.2.1.2 In Vitro Diagnostics-United Kingdom-Drug Testing
5.2.1.3 In Vitro Diagnostics-France-Drug Testing
5.2.1.4 In Vitro Diagnostics-Germany-Drug Testing
5.2.1.5 In Vitro Diagnostics-Italy-Drug Testing
5.2.1.6 In Vitro Diagnostics-Rest of Europe-Drug Testing
5.2.2 In Vitro Diagnostics-Europe-Drug Testing, By Segments
5.2.2.1 Hematology-Europe-Drug Testing
5.2.3 In Vitro Diagnostics-Europe-Drug Testing, By Products
5.2.3.1 Instruments-Europe-Drug Testing
5.2.3.2 Reagents & Kits-Europe-Drug Testing
5.2.3.3 Services & Software-Europe-Drug Testing
6 In Vitro Diagnostics-Europe, By Endusers
6.1 Split By Geography
6.3 In Vitro Diagnostics-Spain by Endusers
6.1 In Vitro Diagnostics-United Kingdom by Endusers
6.1 In Vitro Diagnostics-France by Endusers
6.1 In Vitro Diagnostics-Germany by Endusers
6.1 In Vitro Diagnostics-Italy by Endusers
6.1 In Vitro Diagnostics-Rest of Europe by Endusers
6.2 In Vitro Diagnostics-Europe-Hospitals
6.2.1 In Vitro Diagnostics-Europe-Hospitals, By Geographies
6.2.1.1 In Vitro Diagnostics-France-Hospitals
6.2.1.2 In Vitro Diagnostics-Spain-Hospitals
6.2.1.3 In Vitro Diagnostics-Italy-Hospitals
6.2.1.4 In Vitro Diagnostics-Germany-Hospitals
6.2.1.5 In Vitro Diagnostics-Rest of Europe-Hospitals
6.2.1.6 In Vitro Diagnostics-United Kingdom-Hospitals
6.2.2 In Vitro Diagnostics-Europe-Hospitals, By Segments
6.2.2.1 Molecular Diagnostics-Europe-Hospitals
6.2.2.2 Hematology-Europe-Hospitals
6.2.3 In Vitro Diagnostics-Europe-Hospitals, By Products
6.2.3.1 Instruments-Europe-Hospitals
6.2.3.2 Reagents & Kits-Europe-Hospitals
6.2.3.3 Services & Software-Europe-Hospitals
6.3 In Vitro Diagnostics-Europe-Medical & Diagnostic Laboratories
6.3.1 In Vitro Diagnostics-Europe-Medical & Diagnostic Laboratories, By Geographies
6.3.1.1 In Vitro Diagnostics-Spain-Medical & Diagnostic Laboratories
6.3.1.2 In Vitro Diagnostics-United Kingdom-Medical & Diagnostic Laboratories
6.3.1.3 In Vitro Diagnostics-France-Medical & Diagnostic Laboratories
6.3.1.4 In Vitro Diagnostics-Germany-Medical & Diagnostic Laboratories
6.3.1.5 In Vitro Diagnostics-Italy-Medical & Diagnostic Laboratories
6.3.1.6 In Vitro Diagnostics-Rest of Europe-Medical & Diagnostic Laboratories
6.3.2 In Vitro Diagnostics-Europe-Medical & Diagnostic Laboratories, By Segments
6.3.2.1 Molecular Diagnostics-Europe-Medical & Diagnostic Laboratories
6.3.2.2 Hematology-Europe-Medical & Diagnostic Laboratories
6.3.3 In Vitro Diagnostics-Europe-Medical & Diagnostic Laboratories, By Products
6.3.3.1 Instruments-Europe-Medical & Diagnostic Laboratories
6.3.3.2 Reagents & Kits-Europe-Medical & Diagnostic Laboratories
6.3.3.3 Services & Software-Europe-Medical & Diagnostic Laboratories
6.4 In Vitro Diagnostics-Europe-Patient Self Testing
6.4.1 In Vitro Diagnostics-Europe-Patient Self Testing, By Geographies
6.4.1.1 In Vitro Diagnostics-Spain-Patient Self Testing
6.4.1.2 In Vitro Diagnostics-United Kingdom-Patient Self Testing
6.4.1.3 In Vitro Diagnostics-France-Patient Self Testing
6.4.1.4 In Vitro Diagnostics-Germany-Patient Self Testing
6.4.1.5 In Vitro Diagnostics-Italy-Patient Self Testing
6.4.1.6 In Vitro Diagnostics-Rest of Europe-Patient Self Testing
6.4.2 In Vitro Diagnostics-Europe-Patient Self Testing, By Segments
6.4.2.1 Hematology-Europe-Patient Self Testing
6.4.3 In Vitro Diagnostics-Europe-Patient Self Testing, By Products
6.4.3.1 Instruments-Europe-Patient Self Testing
6.4.3.2 Reagents & Kits-Europe-Patient Self Testing
6.4.3.3 Services & Software-Europe-Patient Self Testing
6.5 In Vitro Diagnostics-Europe-Point of Care Testing
6.5.1 In Vitro Diagnostics-Europe-Point of Care Testing, By Geographies
6.5.1.1 In Vitro Diagnostics-Spain-Point of Care Testing
6.5.1.2 In Vitro Diagnostics-United Kingdom-Point of Care Testing
6.5.1.3 In Vitro Diagnostics-France-Point of Care Testing
6.5.1.4 In Vitro Diagnostics-Germany-Point of Care Testing
6.5.1.5 In Vitro Diagnostics-Italy-Point of Care Testing
6.5.1.6 In Vitro Diagnostics-Rest of Europe-Point of Care Testing
6.5.2 In Vitro Diagnostics-Europe-Point of Care Testing, By Segments
6.5.2.1 Hematology-Europe-Point of Care Testing
6.5.3 In Vitro Diagnostics-Europe-Point of Care Testing, By Products
6.5.3.1 Instruments-Europe-Point of Care Testing
6.5.3.2 Reagents & Kits-Europe-Point of Care Testing
6.5.3.3 Services & Software-Europe-Point of Care Testing
6.6 In Vitro Diagnostics-Europe-Academics
6.6.1 In Vitro Diagnostics-Europe-Academics, By Geographies
6.6.1.1 In Vitro Diagnostics-Spain-Academics
6.6.1.2 In Vitro Diagnostics-United Kingdom-Academics
6.6.1.3 In Vitro Diagnostics-France-Academics
6.6.1.4 In Vitro Diagnostics-Germany-Academics
6.6.1.5 In Vitro Diagnostics-Italy-Academics
6.6.1.6 In Vitro Diagnostics-Rest of Europe-Academics
6.6.2 In Vitro Diagnostics-Europe-Academics, By Segments
6.6.2.1 Hematology-Europe-Academics
6.6.3 In Vitro Diagnostics-Europe-Academics, By Products
6.6.3.1 Instruments-Europe-Academics
6.6.3.2 Reagents & Kits-Europe-Academics
6.6.3.3 Services & Software-Europe-Academics
7 In Vitro Diagnostics-Europe, By Products
7.1 Split By Geography
7.4 In Vitro Diagnostics-Spain by Products
7.1 In Vitro Diagnostics-United Kingdom by Products
7.1 In Vitro Diagnostics-France by Products
7.1 In Vitro Diagnostics-Germany by Products
7.1 In Vitro Diagnostics-Italy by Products
7.1 In Vitro Diagnostics-Rest of Europe by Products
7.2 Instruments-Europe
7.2.1 Instruments-Europe, By Geographies
7.2.1.1 Instruments-Spain
7.2.1.2 Instruments-United Kingdom
7.2.1.3 Instruments-France
7.2.1.4 Instruments-Germany
7.2.1.5 Instruments-Italy
7.2.1.6 Instruments-Rest of Europe
7.3 Reagents & Kits-Europe
7.3.1 Reagents & Kits-Europe, By Geographies
7.3.1.1 Reagents & Kits-Spain
7.3.1.2 Reagents & Kits-United Kingdom
7.3.1.3 Reagents & Kits-France
7.3.1.4 Reagents & Kits-Germany
7.3.1.5 Reagents & Kits-Italy
7.3.1.6 Reagents & Kits-Rest of Europe
7.4 Services & Software-Europe
7.4.1 Services & Software-Europe, By Geographies
7.4.1.1 Services & Software-Spain
7.4.1.2 Services & Software-United Kingdom
7.4.1.3 Services & Software-France
7.4.1.4 Services & Software-Germany
7.4.1.5 Services & Software-Italy
7.4.1.6 Services & Software-Rest of Europe
8 In Vitro Diagnostics-Europe, By Geographies
8.1 In Vitro Diagnostics-Spain
8.1.1 In Vitro Diagnostics-Spain, By Endusers
8.1.1.1 In Vitro Diagnostics-Spain-Patient Self Testing
8.1.1.2 In Vitro Diagnostics-Spain-Point of Care Testing
8.1.1.3 In Vitro Diagnostics-Spain-Academics
8.1.1.4 In Vitro Diagnostics-Spain-Hospitals
8.1.1.5 In Vitro Diagnostics-Spain-Medical & Diagnostic Laboratories
8.1.2 In Vitro Diagnostics-Spain, By Applications
8.1.2.1 In Vitro Diagnostics-Spain-Drug Testing
8.1.3 In Vitro Diagnostics-Spain, By Segments
8.1.3.1 Clinical Chemistry-Spain
8.1.3.2 Immunoassay-Spain
8.1.3.3 Hematology-Spain
8.1.3.4 Coagulation-Spain
8.1.3.5 Microbiology-Spain
8.1.3.6 Others-Spain
8.1.3.7 Molecular Diagnostics-Spain
8.1.4 In Vitro Diagnostics-Spain, By Products
8.1.4.1 Instruments-Spain
8.1.4.2 Reagents & Kits-Spain
8.1.4.3 Services & Software-Spain
8.2 In Vitro Diagnostics-United Kingdom
8.2.1 In Vitro Diagnostics-United Kingdom, By Endusers
8.2.1.1 In Vitro Diagnostics-United Kingdom-Patient Self Testing
8.2.1.2 In Vitro Diagnostics-United Kingdom-Point of Care Testing
8.2.1.3 In Vitro Diagnostics-United Kingdom-Academics
8.2.1.4 In Vitro Diagnostics-United Kingdom-Medical & Diagnostic Laboratories
8.2.1.5 In Vitro Diagnostics-United Kingdom-Hospitals
8.2.2 In Vitro Diagnostics-United Kingdom, By Applications
8.2.2.1 In Vitro Diagnostics-United Kingdom-Drug Testing
8.2.3 In Vitro Diagnostics-United Kingdom, By Segments
8.2.3.1 Clinical Chemistry-United Kingdom
8.2.3.2 Immunoassay-United Kingdom
8.2.3.3 Hematology-United Kingdom
8.2.3.4 Coagulation-United Kingdom
8.2.3.5 Microbiology-United Kingdom
8.2.3.6 Others-United Kingdom
8.2.3.7 Molecular Diagnostics-United Kingdom
8.2.4 In Vitro Diagnostics-United Kingdom, By Products
8.2.4.1 Instruments-United Kingdom
8.2.4.2 Reagents & Kits-United Kingdom
8.2.4.3 Services & Software-United Kingdom
8.3 In Vitro Diagnostics-France
8.3.1 In Vitro Diagnostics-France, By Endusers
8.3.1.1 In Vitro Diagnostics-France-Patient Self Testing
8.3.1.2 In Vitro Diagnostics-France-Point of Care Testing
8.3.1.3 In Vitro Diagnostics-France-Academics
8.3.1.4 In Vitro Diagnostics-France-Hospitals
8.3.1.5 In Vitro Diagnostics-France-Medical & Diagnostic Laboratories
8.3.2 In Vitro Diagnostics-France, By Applications
8.3.2.1 In Vitro Diagnostics-France-Drug Testing
8.3.3 In Vitro Diagnostics-France, By Segments
8.3.3.1 Clinical Chemistry-France
8.3.3.2 Immunoassay-France
8.3.3.3 Hematology-France
8.3.3.4 Coagulation-France
8.3.3.5 Microbiology-France
8.3.3.6 Others-France
8.3.3.7 Molecular Diagnostics-France
8.3.4 In Vitro Diagnostics-France, By Products
8.3.4.1 Instruments-France
8.3.4.2 Reagents & Kits-France
8.3.4.3 Services & Software-France
8.4 In Vitro Diagnostics-Germany
8.4.1 In Vitro Diagnostics-Germany, By Endusers
8.4.1.1 In Vitro Diagnostics-Germany-Patient Self Testing
8.4.1.2 In Vitro Diagnostics-Germany-Point of Care Testing
8.4.1.3 In Vitro Diagnostics-Germany-Academics
8.4.1.4 In Vitro Diagnostics-Germany-Medical & Diagnostic Laboratories
8.4.1.5 In Vitro Diagnostics-Germany-Hospitals
8.4.2 In Vitro Diagnostics-Germany, By Applications
8.4.2.1 In Vitro Diagnostics-Germany-Drug Testing
8.4.3 In Vitro Diagnostics-Germany, By Segments
8.4.3.1 Clinical Chemistry-Germany
8.4.3.2 Immunoassay-Germany
8.4.3.3 Hematology-Germany
8.4.3.4 Coagulation-Germany
8.4.3.5 Microbiology-Germany
8.4.3.6 Others-Germany
8.4.3.7 Molecular Diagnostics-Germany
8.4.4 In Vitro Diagnostics-Germany, By Products
8.4.4.1 Instruments-Germany
8.4.4.2 Reagents & Kits-Germany
8.4.4.3 Services & Software-Germany
8.5 In Vitro Diagnostics-Italy
8.5.1 In Vitro Diagnostics-Italy, By Endusers
8.5.1.1 In Vitro Diagnostics-Italy-Patient Self Testing
8.5.1.2 In Vitro Diagnostics-Italy-Point of Care Testing
8.5.1.3 In Vitro Diagnostics-Italy-Academics
8.5.1.4 In Vitro Diagnostics-Italy-Medical & Diagnostic Laboratories
8.5.1.5 In Vitro Diagnostics-Italy-Hospitals
8.5.2 In Vitro Diagnostics-Italy, By Applications
8.5.2.1 In Vitro Diagnostics-Italy-Drug Testing
8.5.3 In Vitro Diagnostics-Italy, By Segments
8.5.3.1 Clinical Chemistry-Italy
8.5.3.2 Immunoassay-Italy
8.5.3.3 Hematology-Italy
8.5.3.4 Coagulation-Italy
8.5.3.5 Microbiology-Italy
8.5.3.6 Others-Italy
8.5.3.7 Molecular Diagnostics-Italy
8.5.4 In Vitro Diagnostics-Italy, By Products
8.5.4.1 Instruments-Italy
8.5.4.2 Reagents & Kits-Italy
8.5.4.3 Services & Software-Italy
8.6 In Vitro Diagnostics-Rest of Europe
8.6.1 In Vitro Diagnostics-Rest of Europe, By Endusers
8.6.1.1 In Vitro Diagnostics-Rest of Europe-Patient Self Testing
8.6.1.2 In Vitro Diagnostics-Rest of Europe-Point of Care Testing
8.6.1.3 In Vitro Diagnostics-Rest of Europe-Academics
8.6.1.4 In Vitro Diagnostics-Rest of Europe-Medical & Diagnostic Laboratories
8.6.1.5 In Vitro Diagnostics-Rest of Europe-Hospitals
8.6.2 In Vitro Diagnostics-Rest of Europe, By Applications
8.6.2.1 In Vitro Diagnostics-Rest of Europe-Drug Testing
8.6.3 In Vitro Diagnostics-Rest of Europe, By Segments
8.6.3.1 Clinical Chemistry-Rest of Europe
8.6.3.2 Immunoassay-Rest of Europe
8.6.3.3 Hematology-Rest of Europe
8.6.3.4 Coagulation-Rest of Europe
8.6.3.5 Microbiology-Rest of Europe
8.6.3.6 Others-Rest of Europe
8.6.3.7 Molecular Diagnostics-Rest of Europe
8.6.4 In Vitro Diagnostics-Rest of Europe, By Products
8.6.4.1 Instruments-Rest of Europe
8.6.4.2 Reagents & Kits-Rest of Europe
8.6.4.3 Services & Software-Rest of Europe
9 In Vitro Diagnostics-Europe, By Companies
9.1 Competitive landscape
9.2 Split By Geography
9.5 In Vitro Diagnostics-Spain by Companies
9.1 In Vitro Diagnostics-United Kingdom by Companies
9.1 In Vitro Diagnostics-France by Companies
9.1 In Vitro Diagnostics-Germany by Companies
9.1 In Vitro Diagnostics-Italy by Companies
9.1 In Vitro Diagnostics-Rest of Europe by Companies
9.3 In Vitro Diagnostics-Europe-Siemens AG Healthcare
9.3.1 In Vitro Diagnostics-Europe-Siemens AG Healthcare, By Segments
9.3.1.1 Molecular Diagnostics-Europe-Siemens AG Healthcare
9.4 In Vitro Diagnostics-Europe-Abbott Laboratories
9.4.1 In Vitro Diagnostics-Europe-Abbott Laboratories, By Companies
9.4.1.1 In Vitro Diagnostics-Abbott Diagnostics-Europe
9.5 In Vitro Diagnostics-Johnson & Johnson-Europe
9.6 In Vitro Diagnostics-Europe-Thermo Fisher Scientific
9.7 In Vitro Diagnostics-Europe-Other Companies
9.7.1 In Vitro Diagnostics-Europe-Other Companies, By Segments
9.7.1.1 Molecular Diagnostics-Other Companies-Europe
9.7.1.2 Molecular Diagnostics-Other Companies-Europe
9.7.1.3 Molecular Diagnostics-Other Companies-Europe
9.8 In Vitro Diagnostics-Europe-Siemens AG Healthcare
9.8.1 In Vitro Diagnostics-Europe-Siemens AG Healthcare, By Segments
9.8.1.1 Molecular Diagnostics-Europe-Siemens AG Healthcare
9.9 In Vitro Diagnostics-Europe-Abbott Laboratories
9.9.1 In Vitro Diagnostics-Europe-Abbott Laboratories, By Companies
9.9.1.1 In Vitro Diagnostics-Abbott Diagnostics-Europe
9.10 In Vitro Diagnostics-Europe-Thermo Fisher Scientific
9.11 In Vitro Diagnostics-Europe-Other Companies
9.11.1 In Vitro Diagnostics-Europe-Other Companies, By Segments
9.11.1.1 Molecular Diagnostics-Other Companies-Europe
9.11.1.2 Molecular Diagnostics-Other Companies-Europe
9.11.1.3 Molecular Diagnostics-Other Companies-Europe
9.12 In Vitro Diagnostics-Europe-Siemens AG Healthcare
9.12.1 In Vitro Diagnostics-Europe-Siemens AG Healthcare, By Segments
9.12.1.1 Molecular Diagnostics-Europe-Siemens AG Healthcare
9.13 In Vitro Diagnostics-Europe-Abbott Laboratories
9.13.1 In Vitro Diagnostics-Europe-Abbott Laboratories, By Companies
9.13.1.1 In Vitro Diagnostics-Abbott Diagnostics-Europe
9.14 In Vitro Diagnostics-Europe-Thermo Fisher Scientific
9.15 In Vitro Diagnostics-Europe-Other Companies
9.15.1 In Vitro Diagnostics-Europe-Other Companies, By Segments
9.15.1.1 Molecular Diagnostics-Other Companies-Europe
9.15.1.2 Molecular Diagnostics-Other Companies-Europe
9.15.1.3 Molecular Diagnostics-Other Companies-Europe
9.16 In Vitro Diagnostics-F. Hoffmann-La Roche Ltd.-Europe
9.16.1 In Vitro Diagnostics-F. Hoffmann-La Roche Ltd.-Europe, By Companies
9.16.1.1 In Vitro Diagnostics-Europe-Roche 454
9.16.1.2 In Vitro Diagnostics-Europe-Roche 454
9.16.1.3 In Vitro Diagnostics-Europe-Roche 454
9.17 In Vitro Diagnostics-Danaher Corporation-Europe

Please fill in the form below to receive a free copy of the Summary of this Report
















European In Vitro Diagnostics Market

* Enter the text from the image to the text box :

refresh captcha
Custom Market Research Services
We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
PRODUCT TITLE PUBLISHED
Brazil Medical Devices Brazil Medical Devices
Peers of Brazil medical devices are Orthopedic Devices, Ophthalmology devices, Endoscopy and Neurology Devices comprising 12.8%, 9.2%, 7.2% and 1.9% respectively of the Global Medical Devices market. It is segmented on basis of endusers and...
Nov 2015
of items
reports | Show
Connect With Us
US/CAN : +1-888-502-0539